US 8367074
Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
granted A61KA61K2039/5254A61K2039/5256
Quick answer
US patent 8367074 (Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/5254, A61K2039/5256, A61K39/00, A61K39/12